Business
Tandem Diabetes Care to Announce First Quarter 2023 Financial Results on May 3, 2023
SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its
About this update from Tandem Diabetes Care, Inc.
[{"type":"text","content":" SAN DIEGO--(BUSINESS WIRE)--\nTandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its first quarter 2023 results after the financial markets close on Wednesday, May 3, 2023. The Company will hold a conference call and simultaneous webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time), to discuss its first quarter 2023 financial and operating results.\n\n\nA live webcast of the call will be available on Tandem Diabetes Care’s Investor Center website located at http://investor.tandemdiabetes.com in the “Events & Presentations” section. To access the call by phone, please use this link (https://register.vevent.com/register/BI21343b3e346b4b66923ccc4e1bd048e5) and you will be provided with dial-in details, including a personal pin.\n\n\nAn archive of the webcast will be available for 30 days following the event on Tandem Diabetes Care’s Investor Center website located at http://investor.tandemdiabetes.com in the “Events & Presentations” section.\n\n\nAbout Tandem Diabetes Care, Inc.\n\n\nTandem Diabetes Care, Inc., a global insulin delivery and diabetes technology company based in San Diego, California, creates new possibilities for people living with diabetes, their loved ones, and healthcare providers through a positively different experience. The Company’s human-centered approach to design, development, and support delivers innovative products and services for people who use insulin. Tandem manufactures and sells the t:slim X2 insulin pump with Control-IQ technology. For more information, visit tandemdiabetes.com.\n\n\nTandem Diabetes Care and Control-IQ are trademarks registered in the U.S. and/or other countries and t:slim X2 is a trademark of Tandem Diabetes Care, Inc.\n\n\nFollow Tandem Diabetes Care on Twitter @tandemdiabetes; use #tslimX2 and #TandemDiabetes.\nFollow Tandem Diabetes Care on Facebook at www.facebook.com/TandemDiabetes.\nFollow Tandem Diabetes Care on LinkedIn at https://www.linkedin.com/company/tandemdiabetes.\n\nView source version on businesswire.com: https://www.businesswire.com/news/home/20230411005745/en/\n\nMedia Contact:\n858-255-6388\[email protected]\n\nInvestor Contact:\n858-366-6900\[email protected]\n\n\nSource: Tandem Diabetes Care, Inc.","length":5559,"tagName":"div"}]